211 related articles for article (PubMed ID: 22203603)
41. Polymycovirus Infection Sensitizes
Sass G; Kotta-Loizou I; Martinez M; Larwood DJ; Stevens DA
Viruses; 2023 Jan; 15(1):. PubMed ID: 36680240
[TBL] [Abstract][Full Text] [Related]
42. Nanoscopic cell-wall architecture of an immunogenic ligand in Candida albicans during antifungal drug treatment.
Lin J; Wester MJ; Graus MS; Lidke KA; Neumann AK
Mol Biol Cell; 2016 Mar; 27(6):1002-14. PubMed ID: 26792838
[TBL] [Abstract][Full Text] [Related]
43. Antifungal activity against Candida albicans of nikkomycin Z in combination with caspofungin, voriconazole or amphotericin B.
Sandovsky-Losica H; Shwartzman R; Lahat Y; Segal E
J Antimicrob Chemother; 2008 Sep; 62(3):635-7. PubMed ID: 18490373
[No Abstract] [Full Text] [Related]
44. Differential Aspergillus lentulus echinocandin susceptibilities are Fksp independent.
Staab JF; Kahn JN; Marr KA
Antimicrob Agents Chemother; 2010 Dec; 54(12):4992-8. PubMed ID: 20855747
[TBL] [Abstract][Full Text] [Related]
45. Update on antifungals targeted to the cell wall: focus on beta-1,3-glucan synthase inhibitors.
Georgopapadakou NH
Expert Opin Investig Drugs; 2001 Feb; 10(2):269-80. PubMed ID: 11178340
[TBL] [Abstract][Full Text] [Related]
46. Natural products targeting the synthesis of β(1,3)-D-glucan and chitin of the fungal cell wall. Existing drugs and recent findings.
Curto MÁ; Butassi E; Ribas JC; Svetaz LA; Cortés JCG
Phytomedicine; 2021 Jul; 88():153556. PubMed ID: 33958276
[TBL] [Abstract][Full Text] [Related]
47. Hitting the caspofungin salvage pathway of human-pathogenic fungi with the novel lasso peptide humidimycin (MDN-0010).
Valiante V; Monteiro MC; Martín J; Altwasser R; El Aouad N; González I; Kniemeyer O; Mellado E; Palomo S; de Pedro N; Pérez-Victoria I; Tormo JR; Vicente F; Reyes F; Genilloud O; Brakhage AA
Antimicrob Agents Chemother; 2015 Sep; 59(9):5145-53. PubMed ID: 26055366
[TBL] [Abstract][Full Text] [Related]
48. Sequential exposure of Aspergillus fumigatus to itraconazole and caspofungin: evidence of enhanced in vitro activity.
Kontoyiannis DP; Lewis RE; Lionakis MS; Albert ND; May GS; Raad II
Diagn Microbiol Infect Dis; 2003 Oct; 47(2):415-9. PubMed ID: 14522515
[TBL] [Abstract][Full Text] [Related]
49. Poacic acid, a β-1,3-glucan-binding antifungal agent, inhibits cell-wall remodeling and activates transcriptional responses regulated by the cell-wall integrity and high-osmolarity glycerol pathways in yeast.
García R; Itto-Nakama K; Rodríguez-Peña JM; Chen X; Sanz AB; de Lorenzo A; Pavón-Vergés M; Kubo K; Ohnuki S; Nombela C; Popolo L; Ohya Y; Arroyo J
FASEB J; 2021 Sep; 35(9):e21778. PubMed ID: 34383971
[TBL] [Abstract][Full Text] [Related]
50. Tolerance to Caspofungin in Candida albicans Is Associated with at Least Three Distinctive Mechanisms That Govern Expression of
Yang F; Zhang L; Wakabayashi H; Myers J; Jiang Y; Cao Y; Jimenez-Ortigosa C; Perlin DS; Rustchenko E
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223384
[TBL] [Abstract][Full Text] [Related]
51. Cell wall composition plays a key role on sensitivity of filamentous fungi to chitosan.
Aranda-Martinez A; Lopez-Moya F; Lopez-Llorca LV
J Basic Microbiol; 2016 Oct; 56(10):1059-1070. PubMed ID: 27259000
[TBL] [Abstract][Full Text] [Related]
52. The echinocandin B producer fungus Aspergillus nidulans var. roseus ATCC 58397 does not possess innate resistance against its lipopeptide antimycotic.
Tóth V; Nagy CT; Pócsi I; Emri T
Appl Microbiol Biotechnol; 2012 Jul; 95(1):113-22. PubMed ID: 22555909
[TBL] [Abstract][Full Text] [Related]
53. Effect of nikkomycin Z and 50% human serum on the killing activity of high-concentration caspofungin against Candida species using time-kill methodology.
Szilágyi J; Földi R; Bayegan S; Kardos G; Majoros L
J Chemother; 2012 Feb; 24(1):18-25. PubMed ID: 22546720
[TBL] [Abstract][Full Text] [Related]
54. Establishing in vitro-in vivo correlations for Aspergillus fumigatus: the challenge of azoles versus echinocandins.
Arendrup MC; Perkhofer S; Howard SJ; Garcia-Effron G; Vishukumar A; Perlin D; Lass-Flörl C
Antimicrob Agents Chemother; 2008 Oct; 52(10):3504-11. PubMed ID: 18644959
[TBL] [Abstract][Full Text] [Related]
55. Induction of innate immunity by Aspergillus fumigatus cell wall polysaccharides is enhanced by the composite presentation of chitin and beta-glucan.
Dubey LK; Moeller JB; Schlosser A; Sorensen GL; Holmskov U
Immunobiology; 2014 Mar; 219(3):179-88. PubMed ID: 24286790
[TBL] [Abstract][Full Text] [Related]
56. Albumin Enhances Caspofungin Activity against Aspergillus Species by Facilitating Drug Delivery to Germinating Hyphae.
Ioannou P; Andrianaki A; Akoumianaki T; Kyrmizi I; Albert N; Perlin D; Samonis G; Kontoyiannis DP; Chamilos G
Antimicrob Agents Chemother; 2015 Dec; 60(3):1226-33. PubMed ID: 26643329
[TBL] [Abstract][Full Text] [Related]
57. Comparative in vitro pharmacodynamics of caspofungin, micafungin, and anidulafungin against germinated and nongerminated Aspergillus conidia.
Antachopoulos C; Meletiadis J; Sein T; Roilides E; Walsh TJ
Antimicrob Agents Chemother; 2008 Jan; 52(1):321-8. PubMed ID: 17938191
[TBL] [Abstract][Full Text] [Related]
58. Induction of a high affinity fibronectin receptor in Candida albicans by caspofungin: requirements for beta (1,6) glucans and the developmental regulator Hbr1p.
Pendrak ML; Rodrigues RG; Roberts DD
Med Mycol; 2007 Mar; 45(2):157-68. PubMed ID: 17365652
[TBL] [Abstract][Full Text] [Related]
59. Genomic and Molecular Identification of Genes Contributing to the Caspofungin Paradoxical Effect in
Zhao S; Martin-Vicente A; Colabardini AC; Pereira Silva L; Rinker DC; Fortwendel JR; Goldman GH; Gibbons JG
Microbiol Spectr; 2022 Oct; 10(5):e0051922. PubMed ID: 36094204
[TBL] [Abstract][Full Text] [Related]
60. Increases in SLT2 expression and chitin content are associated with incomplete killing of Candida glabrata by caspofungin.
Cota JM; Grabinski JL; Talbert RL; Burgess DS; Rogers PD; Edlind TD; Wiederhold NP
Antimicrob Agents Chemother; 2008 Mar; 52(3):1144-6. PubMed ID: 18086838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
